Lewis and ABO histo-blood types and the secretor status of patients hospitalized with COVID-19 implicate a role for ABO antibodies in susceptibility to infection with SARS-CoV-2
Lewis and ABO histo-blood types and the secretor status of patients hospitalized with COVID-19 implicate a role for ABO antibodies in susceptibility to infection with SARS-CoV-2
Schematic illustration of mucosa cells with glycosylated structures and receptor–ligand interactions. Hormones, antibodies, as well as viruses and bacteria or their toxins, interact with oligosaccharide epitopes (glycoproteins) that serve as receptors or co-receptors. The suggested interference of ABO antibodies with SARS-CoV-2 targeting of host cells via angiotensin-converting enzyme 2 (ACE-2) receptor is indicated. Made with Biorender.com [Color figure can be viewed at wileyonlinelibrary.com]
Patients with blood type Lewis (a−b−) or O were significantly less likely to be hospitalized (odds ratio [OR] 0.669, confidence interval [CI] 0.446–0.971, OR 0.710, CI 0.556–0.900, respectively), while type AB was significantly more prevalent in the patient cohort (OR 1.519, CI 1.014–2.203). The proportions of secretors/nonsecretors, and Lewis a+ or Lewis b+ types were consistent between patients and controls. The analyzed blood groups were not associated with the clinical outcome as defined.
Disclaimer: This blog, all of its content and all of my posts are for Entertainment Purposes Only.
Approval of comments does not equal agreement with content.
Read at your own risk.
Please note that comments will not be approved unless you use your real name.
You can use first name only, if no one else has commented under that name before. Otherwise use first name and last initial.
If that has been taken, use your full first and last name.
No exceptions.
Thank you for understanding.